Lipase News and Research

RSS
New findings show why some people suffer from high levels of triglycerides

New findings show why some people suffer from high levels of triglycerides

FDA grants orphan drug designation for Synageva BioPharma's SBC-102

FDA grants orphan drug designation for Synageva BioPharma's SBC-102

Protea Biosciences, Mayoly-Spindler commence Phase I/IIA human clinical trial for new recombinant Lipase

Protea Biosciences, Mayoly-Spindler commence Phase I/IIA human clinical trial for new recombinant Lipase

ARIAD presents updated positive data on AP24534 pan-BCR-ABL inhibitor for CML at 46th ASCO

ARIAD presents updated positive data on AP24534 pan-BCR-ABL inhibitor for CML at 46th ASCO

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

Report describes imaging features of superior mesenteric artery aneurysm

Report describes imaging features of superior mesenteric artery aneurysm

Synageva BioPharma seeks FDA orphan drug designation for SBC-102 enzyme replacement therapy

Synageva BioPharma seeks FDA orphan drug designation for SBC-102 enzyme replacement therapy

Tufts Medical Center researchers discover new biological pathway for advanced AMD

Tufts Medical Center researchers discover new biological pathway for advanced AMD

AMT announces full year 2009 results; reports modest decrease in operating expenses

AMT announces full year 2009 results; reports modest decrease in operating expenses

Targeted Genetics receives milestone payments from Genzyme and Amsterdam Molecular Therapeutics

Targeted Genetics receives milestone payments from Genzyme and Amsterdam Molecular Therapeutics

Leukemia cells rely on fatty acid metabolism to grow and evade cell death

Leukemia cells rely on fatty acid metabolism to grow and evade cell death

AMT reaches another milestone in the official marketing authorisation process for Glybera

AMT reaches another milestone in the official marketing authorisation process for Glybera

Work provides new insight into potential therapeutic treatments for cancer diseases

Work provides new insight into potential therapeutic treatments for cancer diseases

DSM BioSolutions to manufacture Mayoly Spindler's 'MS1819' lipase biotherapeutic

DSM BioSolutions to manufacture Mayoly Spindler's 'MS1819' lipase biotherapeutic

Positive data from ARIAD Pharmaceuticals' ongoing AP24534 study in advanced hematological cancer patients

Positive data from ARIAD Pharmaceuticals' ongoing AP24534 study in advanced hematological cancer patients

Amsterdam Molecular Therapeutics provides third-quarter 2009 business updates

Amsterdam Molecular Therapeutics provides third-quarter 2009 business updates

AMT inks agreement with Progenika Biopharma for development of LPLchip

AMT inks agreement with Progenika Biopharma for development of LPLchip

Mirafit fbcx reduces human body absorption of consumed fat

Mirafit fbcx reduces human body absorption of consumed fat

New data demonstrates CREON Delayed-Release Capsules improve fat absorption in adults with EPI

New data demonstrates CREON Delayed-Release Capsules improve fat absorption in adults with EPI

Updated data on XL184 study in patients with glioblastoma multiforme presented

Updated data on XL184 study in patients with glioblastoma multiforme presented